Techno Medica (6678) Interim Earnings: Net Sales Up 25.3%, Ordinary Income Surges 937.2% YoY

Techno Medica (6678) announced its interim financial results, reporting net sales of 2,202 million yen (a 25.3% increase year-over-year), operating income of 236 million yen, ordinary income of 243 million yen (a significant increase of 937.2% YoY), and net income of 158 million yen (up 864.7% YoY), demonstrating a sharp recovery and expansion in core profitability across the board.

From a financial and valuation perspective, the company posted a Return on Equity (ROE) of 7.43%, a Return on Assets (ROA) of 5.96%, an equity ratio of 84.4%, and retained earnings of 16.16 billion yen, reflecting an extremely solid financial foundation and high capital efficiency. Supported by an EBITDA of 1.76 billion yen, the company maintains robust earnings capabilities to support future growth.